Deal · Completed
Laws of the Cayman Islands and Theravance Biopharma, Inc.
First filed 23 Sept 2026, 1 filing.
The deal
- Buyer
- Laws of the Cayman Islands
- Target
- Theravance Biopharma, Inc.
- Status
- Completed
- Region
- US
This Current Report on Form 8-K is being filed in connection with the completion on September 23, 2026 of the transactions contemplated by that certain Agreement and Plan of Merger (the " Merger Agreement "), dated as of June 28, 2026, by and among Theravance Biopharma, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the " Company "), Zymework...
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.